Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BoNTA for Chronic Pelvic Floor Pain
NCT03715777Phase 3Completed
- Start
- Oct 2018
- Primary completion
- Apr 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of botulinum toxin type A in chronic pelvic pain (CPP). Primary endpoint: Visual Analog Scale for Pain at 24 weeks. Started Oct 2018; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
chronic pelvic pain (CPP)
Beyond the preview
Go deeper on NCT03715777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03715777.